MLchartDataset catalogue

delta-8-tetrahydrocannabinol

Term · Oncology and biomedicine · MLC-T-ONC-012956

An analogue of tetrahydrocannabinol (THC), with potential antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective activities. Delta-8-tetrahydrocannabinol (delta-8-THC) binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system; CB1 receptor activation may inhibit adenyl cyclase, increase mitogen-activated protein kinase activities, modulate several potassium channel conductances and inhibit N- and P/Q-type Ca2+ channels. This agent exhibits a lower psychotropic potency than delta-9-tetrahydrocannabinol (delta-9-THC), the primary form of THC found in cannabis.

Table 1. Record
IdentifierMLC-T-ONC-012956
FieldOncology and biomedicine
Abbreviationdelta-8-THC
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012956",
  "term": "delta-8-tetrahydrocannabinol",
  "field": "Oncology and biomedicine",
  "definition": "An analogue of tetrahydrocannabinol (THC), with potential antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective activities. Delta-8-tetrahydrocannabinol (delta-8-THC) binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system; CB1 receptor activation may inhibit adenyl cyclase, increase mitogen-activated protein kinase activities, modulate several potassium channel conductances and inhibit N- and P/Q-type Ca2+ channels. This agent exhibits a lower psychotropic potency than delta-9-tetrahydrocannabinol (delta-9-THC), the primary form of THC found in cannabis.",
  "abbreviation": "delta-8-THC",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/delta-8-tetrahydrocannabinol/"
}

Record 5,795 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.